Fig. 2From: Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett’s esophagusFlow diagram illustrating EAC samples selection process. One hundred and forty-five EAC patients were subjected to targeted molecular profiling, among which 37 were removed from the main data set due to the absence of tumor or low tumor cell content (< 5%). Only samples from 108 patients were used for determination of alterations frequenciesBack to article page